Fresenius Medical Care AG KGaA ROE 2010-2022 | FMS

Current and historical return on equity (ROE) values for Fresenius Medical Care AG KGaA (FMS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Fresenius Medical Care AG KGaA ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2022-09-30 $0.83B $16.86B 5.00%
2022-06-30 $0.92B $16.44B 5.63%
2022-03-31 $1.02B $16.32B 6.38%
2021-12-31 $1.15B $16.54B 7.19%
2021-09-30 $1.10B $15.86B 7.20%
2021-06-30 $1.19B $15.44B 7.93%
2021-03-31 $1.32B $15.91B 8.86%
2020-12-31 $1.33B $14.09B 9.14%
2020-09-30 $1.49B $14.80B 10.13%
2020-06-30 $1.45B $14.67B 9.79%
2020-03-31 $1.35B $14.64B 9.15%
2019-12-31 $1.34B $14.82B 9.07%
2019-09-30 $1.45B $15.06B 9.68%
2019-06-30 $1.41B $14.39B 9.53%
2019-03-31 $2.31B $15.02B 15.66%
2018-12-31 $2.34B $15.24B 16.34%
2018-09-30 $2.32B $14.36B 17.07%
2018-06-30 $2.35B $14.29B 17.90%
2018-03-31 $1.46B $13.41B 11.69%
2017-12-31 $1.45B $12.24B 11.90%
2017-09-30 $1.38B $12.54B 11.51%
2017-06-30 $1.35B $11.76B 11.57%
2017-03-31 $1.34B $12.04B 11.79%
2016-12-31 $1.24B $11.46B 11.22%
2016-09-30 $1.17B $11.24B 10.81%
2016-06-30 $1.10B $10.83B 10.39%
2016-03-31 $1.05B $10.81B 9.99%
2015-12-31 $1.03B $10.50B 9.92%
2015-09-30 $1.05B $10.24B 10.20%
2015-06-30 $1.06B $10.43B 10.22%
2015-03-31 $1.05B $10.38B 10.18%
2014-12-31 $1.05B $10.03B 10.15%
2014-09-30 $1.06B $10.52B 10.26%
2014-06-30 $1.06B $10.32B 10.48%
2014-03-31 $1.09B $10.31B 10.95%
2013-12-31 $1.11B $10.13B 11.26%
2013-09-30 $1.02B $9.74B 10.44%
2013-06-30 $1.02B $9.65B 10.49%
2013-03-31 $1.04B $9.90B 10.94%
2012-12-31 $1.19B $9.73B 12.71%
2012-09-30 $1.24B $9.44B 13.74%
2012-06-30 $1.25B $9.01B 14.33%
2012-03-31 $1.22B $9.14B 14.33%
2011-12-31 $1.07B $8.47B 13.06%
2011-09-30 $1.03B $8.22B 12.85%
2011-06-30 $1.00B $8.23B 12.76%
2011-03-31 $0.99B $7.88B 13.14%
2010-12-31 $0.98B $7.80B 13.34%
2010-09-30 $0.95B $7.47B 13.36%
2010-06-30 $0.93B $6.93B 13.40%
2010-03-31 $0.90B $7.13B 13.27%
2009-12-31 $0.89B $7.03B 13.51%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.600B $20.846B
Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products..
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00